Glenmark Pharma, Glenmark Life: The fresh move, analysts said, may help Glenmark Pharma pare debt and increase its emphasis on branded or innovative products, they said.
Bajaj Finance's execution over the past decade across growth, asset quality and profitability has been impeccable, said Investec with a 'sell' rating and a target price of Rs 4,800.